|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004057,
umls-concept:C0040018,
umls-concept:C0079411,
umls-concept:C0175677,
umls-concept:C0205145,
umls-concept:C0221099,
umls-concept:C0245726,
umls-concept:C0332281,
umls-concept:C0441472,
umls-concept:C1882417,
umls-concept:C2349975
|
|
pubmed:issue |
22
|
|
pubmed:dateCreated |
2001-11-27
|
|
pubmed:abstractText |
Mechanisms by which the Pl(A2) (Leu33Pro) polymorphism of beta(3) integrins could lead to an increased risk for coronary events are unclear. This study was designed to examine the effect of this polymorphism on blood coagulation.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Aspirin,
http://linkedlifedata.com/resource/pubmed/chemical/Factor V,
http://linkedlifedata.com/resource/pubmed/chemical/Factor XIII,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrinogen,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Integrin beta3,
http://linkedlifedata.com/resource/pubmed/chemical/Phospholipases A,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Prothrombin,
http://linkedlifedata.com/resource/pubmed/chemical/Thrombin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
27
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2666-72
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:11723016-Adult,
pubmed-meshheading:11723016-Alleles,
pubmed-meshheading:11723016-Antigens, CD,
pubmed-meshheading:11723016-Aspirin,
pubmed-meshheading:11723016-Blood Coagulation,
pubmed-meshheading:11723016-Blood Coagulation Tests,
pubmed-meshheading:11723016-Coronary Thrombosis,
pubmed-meshheading:11723016-Factor V,
pubmed-meshheading:11723016-Factor XIII,
pubmed-meshheading:11723016-Fibrinogen,
pubmed-meshheading:11723016-Fibrinolytic Agents,
pubmed-meshheading:11723016-Genetic Testing,
pubmed-meshheading:11723016-Genotype,
pubmed-meshheading:11723016-Heterozygote,
pubmed-meshheading:11723016-Homozygote,
pubmed-meshheading:11723016-Humans,
pubmed-meshheading:11723016-Integrin beta3,
pubmed-meshheading:11723016-Male,
pubmed-meshheading:11723016-Microcirculation,
pubmed-meshheading:11723016-Phospholipases A,
pubmed-meshheading:11723016-Platelet Membrane Glycoproteins,
pubmed-meshheading:11723016-Polymorphism, Genetic,
pubmed-meshheading:11723016-Prothrombin,
pubmed-meshheading:11723016-Skin,
pubmed-meshheading:11723016-Thrombin
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury.
|
|
pubmed:affiliation |
Department of Medicine, Jagellonian University School of Medicine, Krakow, Poland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Controlled Clinical Trial
|
